BABYLAX 1.8 G RECTAL SOLUTION 1.8 Grams Rectal Solution
Land: Irland
Språk: engelska
Källa: HPRA (Health Products Regulatory Authority)
Produktens egenskaper
(SPC)
16-04-2024
Vissa dokument för denna produkt är för närvarande inte tillgängliga, du kan skicka en begäran till vår kundservice och vi kommer att meddela dig så snart vi kan få dem.
Skicka förfrågan.
Skicka förfrågan.
Aktiva substanser:
GLYCEROL 85%
Tillgänglig från:
Bausch & Lomb UK Limited
INN (International namn):
GLYCEROL 85%
Dos:
1.8 Grams
Läkemedelsform:
Rectal Solution
Receptbelagda typ:
Product not subject to medical prescription
Bemyndigande status:
Authorised
Tillstånd datum:
0000-00-00
Produktens egenskaper
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Babylax 1.8 g Rectal Solution.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Glycerol (85%) 1.8 g per applicator.
Excipients: Each applicator contains 0.36mg of benzalkonium chloride.
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Rectal solution.
Clear, colourless, rectal solution.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
In the treatment of constipation.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
For rectal use only.
Under 3 months: ½ to 1 applicator.
Over 3 months up to 6 years: 1 applicator.
Children over 6 years: 1 - 2 applicators.
Adults and elderly: 1 - 2 applicators.
4.3 CONTRAINDICATIONS
None.
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
If constipation persists, consult your doctor.
4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION
None.
4.6 FERTILITY, PREGNANCY AND LACTATION
None.
4.7 EFFECTS ON ABILITY TO DRIVE AND USE MACHINES
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 26/11/2010_
_CRN 2090792_
_page number: 1_
None.
4.8 UNDESIRABLE EFFECTS
Prolonged use may lead to irritation of the anal canal.
4.9 OVERDOSE
None.
5 PHARMACOLOGICAL PROPERTIES
5.1 PHARMACODYNAMIC PROPERTIES
Glycerol is a trivalent alcohol. When glycerol is given rectally, it promotes peristalsis and evacuation of the lower
bowel by virtue of its irritant action, so that defecation stimulus is increased.
5.2 PHARMACOKINETIC PROPERTIES
There is a slight absorption of glycerol from the rectum. The elimination of absorbed glycerol is via the kidneys.
5.3 PRECLINICAL SAFETY DATA
(Registry of toxic Effects of Chemical Substances 1987)
6 PHARMACEUTICAL PARTICULARS
6.1 LIST OF EXCIPIENTS
Benzalkonium chloride
Mac
Läs hela dokumentet
